These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6757976)

  • 1. Dosage regimen design.
    DeVane CL; Jusko WJ
    Pharmacol Ther; 1982; 17(2):143-63. PubMed ID: 6757976
    [No Abstract]   [Full Text] [Related]  

  • 2. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.
    Chiou WL; Gadalla MA; Peng GW
    J Pharmacokinet Biopharm; 1978 Apr; 6(2):135-51. PubMed ID: 671220
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid attainment of successively higher steady-state plasma levels using the Wagner two-step infusion method.
    Zimmerman JJ
    J Pharm Sci; 1978 Dec; 67(12):1651-6. PubMed ID: 722475
    [No Abstract]   [Full Text] [Related]  

  • 4. Using pharmacokinetics in drug therapy III: Estimating dosage regimens and blood levels using the fraction-lost method.
    Schumacher GE
    Am J Hosp Pharm; 1978 Aug; 35(8):955-8. PubMed ID: 677145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A safe method for rapidly achieving plasma concentration plateaus.
    Wagner JG
    Clin Pharmacol Ther; 1974 Oct; 16(4):691-700. PubMed ID: 4420442
    [No Abstract]   [Full Text] [Related]  

  • 6. Multicompartment pharmacokinetic analysis and simulations using a programmable calculator.
    Niazi S
    Int J Biomed Comput; 1979 May; 10(3):245-55. PubMed ID: 489156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of infusion regimens to achieve and maintain a predetermined plasma drug level range.
    Tsuei SE; Nation RL; Thomas J
    Clin Pharmacol Ther; 1980 Sep; 28(3):289-95. PubMed ID: 7408388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized estimation of clearance following a loading dose and continuous intravenous infusion using a programmable calculator.
    Mitsuoka JC; Fleck RJ
    Comput Programs Biomed; 1983; 16(1-2):21-5. PubMed ID: 6687852
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal dosage regimen calculation program based on the remaining drug concentrations in plasma.
    Takada K; Yoshikawa H; Muranishi S
    Int J Biomed Comput; 1985 May; 16(3-4):267-75. PubMed ID: 3839212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method for controlled establishment of steady-state plasma levels through multiple dosing.
    Weiss M; Förster W
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):102-4. PubMed ID: 649225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodicity during the distributive phase for drugs administered intravenously to humans.
    Wood JH; Lee AJ; Garrettson LK
    Drug Metab Rev; 1979; 9(1):119-28. PubMed ID: 446264
    [No Abstract]   [Full Text] [Related]  

  • 12. Consecutive intravenous infusions: simulation of two compartment pharmacokinetic drugs.
    Hieb BR; Shrewsbury B
    Comput Programs Biomed; 1980 Dec; 12(2-3):96-104. PubMed ID: 7249608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of infusion pump fill-stroke flow interruptions on simulated serum concentrations of short half-life drugs.
    Floyd RA
    Am J Hosp Pharm; 1984 Nov; 41(11):2399-400. PubMed ID: 6507446
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems in paediatric prescribing.
    Catzel P
    Practitioner; 1976 Sep; 217(1299):396-402. PubMed ID: 981131
    [No Abstract]   [Full Text] [Related]  

  • 15. Dosage regimen design: a pharmacokinetic approach.
    Thompson GA
    J Clin Pharmacol; 1992 Mar; 32(3):210-4. PubMed ID: 1564124
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of infusion time on the time course of drug concentration in blood.
    Raymond K; Morgan DJ
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):573-82. PubMed ID: 7229909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 18. The urinary elimination "time lag": determination of the mean residence time from drug accumulation in the urine during infusion.
    Siegel RA
    J Pharm Sci; 1986 Jun; 75(6):627-8. PubMed ID: 3735112
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on absorption and elimination of drugs.
    Ksiezyk M; Danek A
    Int J Clin Pharmacol; 1973 Nov; 8(3):222-7. PubMed ID: 4272488
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosage calculations for drugs administered by infusion.
    Zenk KE
    Am J Hosp Pharm; 1980 Oct; 37(10):1304-5. PubMed ID: 7424921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.